These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22045708)

  • 1. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
    Vangestel C; Van de Wiele C; Van Damme N; Staelens S; Pauwels P; Reutelingsperger CP; Peeters M
    J Nucl Med; 2011 Nov; 52(11):1786-94. PubMed ID: 22045708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.
    Vangestel C; Van de Wiele C; Mees G; Mertens K; Staelens S; Reutelingsperger C; Pauwels P; Van Damme N; Peeters M
    Mol Imaging; 2012 Apr; 11(2):135-47. PubMed ID: 22469241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Looking through the vascular normalization window: timing antiangiogenic treatment and chemotherapy with (99m)Tc-annexin A5.
    Lewis MR
    J Nucl Med; 2011 Nov; 52(11):1670-2. PubMed ID: 21994408
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
    Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
    Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.
    Elvas F; Vangestel C; Pak K; Vermeulen P; Gray B; Stroobants S; Staelens S; Wyffels L
    J Nucl Med; 2016 May; 57(5):805-11. PubMed ID: 26837335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of novel agents in the treatment of colorectal cancer.
    Iqbal S; Lenz HJ
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
    Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
    Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of adenosine preconditioning with 99mTc-His10-annexin V in a porcine model of myocardium ischemia and reperfusion injury: preliminary study.
    Ye F; Fang W; Wang F; Hua ZC; Wang Z; Yang X
    Nucl Med Biol; 2011 May; 38(4):567-74. PubMed ID: 21531294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.
    Dickson PV; Hamner JB; Sims TL; Fraga CH; Ng CY; Rajasekeran S; Hagedorn NL; McCarville MB; Stewart CF; Davidoff AM
    Clin Cancer Res; 2007 Jul; 13(13):3942-50. PubMed ID: 17606728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
    Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
    Mochizuki T; Kuge Y; Zhao S; Tsukamoto E; Hosokawa M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
    J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-annexin V uptake and histologic findings in an experimental model.
    Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
    J Nucl Med; 2004 Dec; 45(12):2083-7. PubMed ID: 15585485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of radiation-induced tissue apoptosis by (99m)Tc(I)-his (6)-annexin A5.
    Lin KJ; Wu CC; Pan YH; Chen FH; Fu SY; Chiang CS; Hong JH; Lo JM
    Ann Nucl Med; 2012 Apr; 26(3):272-80. PubMed ID: 22278351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake.
    Arjaans M; Oude Munnink TH; Oosting SF; Terwisscha van Scheltinga AG; Gietema JA; Garbacik ET; Timmer-Bosscha H; Lub-de Hooge MN; Schröder CP; de Vries EG
    Cancer Res; 2013 Jun; 73(11):3347-55. PubMed ID: 23580572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
    Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G
    J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.
    Belhocine TZ; Blankenberg FG; Kartachova MS; Stitt LW; Vanderheyden JL; Hoebers FJ; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2083-97. PubMed ID: 26275392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model.
    Heijmen L; Ter Voert EG; Punt CJ; Heerschap A; Oyen WJ; Bussink J; Sweep CG; Laverman P; Span PN; de Geus-Oei LF; Boerman OC; van Laarhoven HW
    Contrast Media Mol Imaging; 2014; 9(3):237-45. PubMed ID: 24700751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
    Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
    J Nucl Med; 2005 May; 46(5):794-9. PubMed ID: 15872353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
    Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
    J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.